Argitalpenak (29) MARIA DEL CARMEN GONZALEZ MONTELONGO argitalpenak

2024

  1. Changes in Adhesion and the Expression of Adhesion Molecules in PBMCs after Aneurysmal Subarachnoid Hemorrhage: Relation to Cerebral Vasospasm

    Translational Stroke Research, Vol. 15, Núm. 2, pp. 378-387

  2. Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model

    Vascular Pharmacology, Vol. 155

  3. Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries

    Vascular Pharmacology, Vol. 151, pp. 107192

2022

  1. A New Perspective on Huntington’s Disease: How a Neurological Disorder Influences the Peripheral Tissues

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  2. Is mouse retinal affectation by HTT cag expansion suitable for modelling the neuroinflammatory component of Huntington’s disease?

    B: Models for HD

  3. Synthesis and Antioxidant/Anti-Inflammatory Activity of 3-Arylphthalides

    Pharmaceuticals, Vol. 15, Núm. 5

  4. Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Diterpenoids from the brown alga rugulopteryx okamurae and their anti-inflammatory activity

    Marine Drugs, Vol. 19, Núm. 12

  2. Immunomodulation of Microglia/Macrophage Interaction and its Effect in Diabetic Retinopathy Progression

    Meeting of the European Association for the Study of Diabetes Eye Complications Study Group (EASDec), Vol. 31, Núm. 2_suppl, pp. 1-41

  3. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses

    Vascular Pharmacology, Vol. 136

2019

  1. Mechanism of neuropeptide Y mediated potentiation of P2X1 receptordependent vasoconstriction in human and mouse small arteries

    Pharmacology 2019

  2. PKCα-mediated downregulation of RhoA activity in depolarized vascular smooth muscle: Synergistic vasorelaxant effect of PKCα and ROCK inhibition

    Cellular Physiology and Biochemistry, Vol. 52, Núm. 1, pp. 76-93

  3. RhoA in aneurysmal subarachnoid hemorrhage

    Aging

2018

  1. Neuropeptide Y potentiates a, b‐methylene ATP‐evoked contractions via NPY receptors 1 and 2 in mouse mesenteric arteries

    Pharmacology 2018

  2. Relation of RhoA in peripheral blood mononuclear cells with severity of aneurysmal subarachnoid hemorrhage and vasospasm

    Stroke, Vol. 49, Núm. 6, pp. 1507-1510

2015

  1. Role of L-type Ca2+ channels, sarcoplasmic reticulum and Rho kinase in rat basilar artery contractile properties in a new model of subarachnoid hemorrhage

    Vascular Pharmacology, Vol. 72, pp. 64-72

2014

  1. A new functional role of Ca2+ sensitization mechanisms in the regulation of vascular smooth muscle contraction

    Joint meeting of the Federation of European Physiological Societies (FEPS) and the Hungarian Physiological Society

  2. Addition of docosahexaenoic acid, but not arachidonic acid, activates glutathione and thioredoxin antioxidant systems in murine hippocampal HT22 cells: Potential implications in neuroprotection

    Journal of Neurochemistry, Vol. 131, Núm. 4, pp. 470-483

  3. Contractile responses to rat urotensin II in resting and depolarized basilar arteries

    Journal of Physiology and Biochemistry, Vol. 70, Núm. 1, pp. 193-199